| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0003 | 1 |